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ATM speciﬁcally mediates repair of double-strand
breaks with blocked DNA ends
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Ataxia telangiectasia is caused by mutations in ATM and represents a paradigm for cancer
predisposition and neurodegenerative syndromes linked to deﬁciencies in the DNA-damage
response. The role of ATM as a key regulator of signalling following DNA double-strand
breaks (DSBs) has been dissected in extraordinary detail, but the impact of this process on
DSB repair still remains controversial. Here we develop novel genetic and molecular tools to
modify the structure of DSB ends and demonstrate that ATM is indeed required for efﬁcient
and accurate DSB repair, preventing cell death and genome instability, but exclusively when
the ends are irreversibly blocked. We therefore identify the nature of ATM involvement
in DSB repair, presenting blocked DNA ends as a possible pathogenic trigger of ataxia
telangiectasia and related disorders.
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D
eﬁciencies in the DNA-damage response (DDR) are the
cause of several human genetic syndromes1. Common
hallmarks of these disorders include neurodegeneration
and/or cancer predisposition, which are a probable consequence
of deﬁcient and inaccurate repair of DNA damage. Ataxia
telangiectasia (A-T), a rare autosomal recessive syndrome that
results from inactivation of the PIKK family Ser/Thr protein
kinase ATM (A-T Mutated), is perhaps the paradigm for diseases
of this type2,3. It is characterized by a symptomatology
that includes progressive cerebellar ataxia, immunodeﬁciency,
radiosensitivity, hypogonadism and increased cancer incidence
(mainly leukaemia and lymphoma). Multiple functions have been
assigned to ATM and its list of phosphorylation substrates is
extensive4. Despite this versatility, its main function, or at least
the best understood, is to trigger the initial phosphorylation wave
of the DDR to double-strand breaks (DSBs). This fact, together
with the exquisite radiosensitivity displayed by ATM-deﬁcient
cells and individuals and the symptomatological overlap of A-T
with other break repair-defective human syndromes, strongly
suggests a link between DSBs and pathology in A-T patients3,5.
On the basis of all of this, one could anticipate that ATM would
be essential, or at least important, for the repair of DSBs. Strikingly,
this is not the case, as ATM loss does not result in obvious defects
in the DSB repair rate. It has therefore been proposed that the
radiosensitivity and chromosomal instability observed in ATM-
deﬁcient cells more likely arises from deﬁcient checkpoint allowing
cell cycle progression in the presence of damaged DNA6. However,
there is a subset of DSBs, 10–20% depending on the DNA-
damaging agent used7,8, which do require ATM. The current
understanding is that these DSBs correspond to damage occurring
in heterochromatin, where ATM is required to open the chromatin
structure, allowing access of the repair machinery9. Interestingly, in
addition to this, ATM is involved in specialized DSB-repair
mechanisms that are not heterochromatin associated, such as
V(D)J, class-switching and meiotic recombination10–12. These
processes are related to important aspects of A-T pathogenesis
such as immunodeﬁciency, increased incidence of lymphoma and
sterility. Fully understanding the nature of DSBs that speciﬁcally
require ATM for repair could therefore provide important clues
into disease pathogenesis.
DSBs can harbour different types of chemical moieties that differ
from the canonical 50 phosphate and 30 hydroxyl at the ends13.
Cells are therefore endowed with a wide variety of enzymatic
activities that can ‘unblock’ DSBs preparing them for repair.
However, under certain circumstances, such as the presence of
complex or staggered lesions, these activities may be compromised
or overwhelmed, resulting in breaks that are ‘blocked,’ in which
case the only possibility to allow repair involves the action of
nucleases to ‘process’ the ends by cleaving DNA sequence. It is
therefore conceivable that clean and blocked DSBs can have
different repair requirements and consequences. However, the
study of how DNA-end complexity inﬂuences the DDR and repair
has been traditionally impeded by the heterogeneity in the breaks
induced by most DNA-damaging agents.
A particular source of DNA breaks is the abortive activity of
DNA topoisomerase II (TOP2, a and b isoforms)14, which are
essential homodimeric enzymes that relax, unknot and/or
decatenate DNA molecules15. The a isoform is speciﬁc to cycling
cells, having essential functions during replication and
chromosome condensation and segregation. In contrast, the
TOP2b is the main TOP2 isoform in quiescent cells and acts
mainly in transcription. Despite the important function of TOP2 in
essential processes of chromosome metabolism, its mechanism of
action can be dangerous, as it involves the passage of duplex DNA
through a transient DSB created by the enzyme. This key
intermediate of TOP2 activity (termed cleavage complex), in
which two topoisomerase subunits are covalently linked to each
50-terminus of a DSB via a phosphodiester bond between the
active-site tyrosine and the 50-phosphate, is normally very short-
lived, because the topoisomerase rapidly religates the DSB once
DNA strand passage through the gap has occurred. However,
under certain circumstances, such as the presence of nearby DNA
lesions, cleavage complexes can be stabilized and interfere with the
transcription or replication machinery. If this is the case, trapped
TOP2 is degraded, leading to the formation of irreversible DSBs
with peptidic blockages at the 50 ends of the DNA. This mechanism
underlies the clinical efﬁcacy of a widely used class of antitumour
agents that ‘poison’ topoisomerase activity (for example,
etoposide)16, thereby prolonging the half-life of the intermediate
and increasing the possibility of DSB formation16.
Etoposide can therefore be used to generate DSBs homo-
geneously characterized by covalent peptide blockage of the 50
ends. Tyrosyl DNA phosphodiesterase 2 (TDP2) is the only
known enzyme in higher eukaryotes with the physiological
capacity to unblock this type of DNA ends, converting them into
50 phosphate/30 hydroxyl ligatable termini17–19. This scenario
offers a unique opportunity for the speciﬁc induction of clean and
blocked DSBs (Fig. 1a). Following etoposide treatment, the
majority of the induced DSBs will be efﬁciently unblocked by
TDP2 in wild-type cells. However, when TDP2 is not present, the
blockage will be irreversible and will necessarily require
alternative nucleolytic processing to allow repair to proceed.
This way, clean and blocked DSBs can be speciﬁcally induced by
etoposide treatment of wild-type and TDP2-deﬁcient cells,
respectively.
In this study, we exploit this genetic tool to demonstrate that
ATM functions speciﬁcally in the rejoining of blocked DSBs, in a
manner that is independent of the chromatin status of the lesions.
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Figure 1 | Protein-blocked DSBs accumulate in Tdp2-deﬁcient
background upon TOP2 poison treatment. (a) Scheme of the strategy
used to generate breaks with speciﬁc structure. (b) SLOPE assay performed
in Tdp2þ /þ and Tdp2 / conﬂuency-arrested primary MEFs.
Average±s.e.m. of signal from three independent experiments and
statistical signiﬁcance by two-way ANOVA test with Bonferroni post-test is
shown (*Pr0.05; **Pr0.01; ***Pr0.001).
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We determine that this novel ATM-dependent repair pathway is
particularly relevant for cell survival and the maintenance of
genome stability upon induction of blocked DSBs. Finally, we
conﬁrm these results using a molecularly deﬁned system and
determine that ATM functions in promoting appropriate
processing of blocked DSBs. These results put forwards DNA-
end structure as a key factor determining ATM involvement
during DSB repair, something that could have important
implications on our understanding of A-T pathogenesis.
Results
Protein-blocked DSBs accumulate in the absence of TDP2. As
mentioned above, we can use TOP2 poisons such as etoposide to
induce DSBs that are homogeneous in structure. Furthermore,
theoretically, we can modulate the ends of these DSBs by working
in different genetic backgrounds (Fig. 1a): 30-hydroxyl 50-phos-
phate clean ends will be formed in cells containing TDP2 activity,
while breaks with a peptide block on 50 ends will accumulate in
TDP2-deﬁcient cells. To validate this experimental setup, we
aimed at developing a methodology to speciﬁcally measure pro-
tein-blocked DSBs, which we have named SLOPE (Selective
Labelling Of Protein-blocked Ends). It is based on a previously
described assay that has been used to identify genomic regions of
TOP2 cleavage20. Following isolation of genomic DNA with
standard Proteinase K treatment and silica columns, tyrosine
residues will remain covalently linked to DNA at the sites of
TOP2-blocked DSBs. Biotin is then speciﬁcally conjugated to
these residues, and ﬁnally, the amount of biotin conjugation is
measured in dot blots, and used as a speciﬁc indicator of protein
covalently linked to DNA. To speciﬁcally detect irreversible
TOP2-blocked DSBs resulting from etoposide treatment, cells are
incubated in the absence of the drug to allow cleavage complex
reversal before DNA isolation. As can be seen in Fig. 1b,
incubation of wild-type primary mouse embryonic ﬁbroblasts
(MEFs) with etoposide did not detectably change the amount of
protein covalently linked to DNA compared with untreated
samples, while a clear and signiﬁcant increase was observed in
Tdp2 / cells. These results experimentally demonstrate that,
upon etoposide treatment, protein-blocked DSBs accumulate in
TDP2-deﬁcient cells, validating our genetic approach for
inducing DSBs with different structure.
ATM facilitates repair of TOP2-blocked but not clean DSBs.
We decided to apply the experimental setup described above to
analyse the impact of ATM loss on the repair of either clean or
blocked DSBs. As an indicator of DSB repair, we followed the
time course of Ser139-phosphorylated H2AX (gH2AX) foci dis-
appearance in primary MEFs after etoposide treatment. Since
TOP2 activity is subject to cell cycle variations21,22, cells were
conﬂuency arrested to avoid discrepancies in DSB induction. In
addition, this simpliﬁes the interpretation of the results, as DSB
repair during G0/G1 is limited to non-homologous end-joining23.
We found that the absence of ATM caused a marked reduction in
the intensity of etoposide-induced gH2AX foci (Supplementary
Fig. 1a); this is not surprising given the key involvement of ATM
in H2AX phosphorylation in response to DSBs. However, the
number of gH2AX foci per cell was not affected, validating the
use of this parameter as a DSB-scoring tool in our setup. In
addition, consistent with identical DSB induction, cleavage
complexes of TOP2b (the main source of TOP2 activity in
quiescent cells22) were also accumulated at similar levels
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Figure 2 | ATM facilitates repair of TOP2-blocked DSBs. (a) Time course of gH2AX foci disappearance after 30min 10mM etoposide treatment and
repair at different times following drug removal in Tdp2þ /þ Atmþ /þ , Tdp2þ /þ Atm / , Tdp2 / Atmþ /þ and Tdp2 / Atm / conﬂuency-
arrested primary MEFs. Representative images of gH2AX foci (green) and DAPI counterstain (blue) for the 24 h repair time point are shown. Scale bar,
10mm. (b) As above, in Tdp2þ /þ and Tdp2 / conﬂuency-arrested primary MEFs with or without 10mM ATM inhibitor (KU55933). (c) As above, in
conﬂuency-arrested primary ﬁbroblast derived from A-Tpatients (AT) and wild-type controls (BJ1) depleted (shTDP2) or not for TDP2. In this case 20 mM
etoposide treatment was applied. In all cases, average±s.e.m. of the percentage of foci remaining from at least three independent experiments and the
minimal statistical signiﬁcance between cells deﬁcient in both TDP2 and ATM and all other cells by two-way ANOVA test with Bonferroni post-test is
shown (*Pr0.05; **Pr0.01; ***Pr0.001).
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(Supplementary Fig. 1b), ruling out an effect of ATM in the
generation and processing of TOP2 cleavage complexes.
As can be seen in Fig. 2a, the difference in repair rate between
Tdp2þ /þ and Tdp2 / cells was only minor at the etoposide
dose used, which was chosen to avoid artefacts of overwhelming
cellular repair capacity. Furthermore, the absence of ATM did
not affect the rate of etoposide-induced DSB repair in a TDP2-
proﬁcient background. This is consistent with previous
observations of a limited DSB-repair defect for IR- but not for
etoposide-induced DSBs8. ATM, therefore, does not inﬂuence
repair of clean DSBs. In contrast, a striking drop in the repair
kinetics was observed in double Tdp2 / Atm / cells, with
B40% of the breaks remaining unrepaired even 24 h after
induction (Fig. 2a and Supplementary Fig. 2a), suggesting that
ATM facilitates repair when DSBs are blocked. A single copy of
the Tdp2 gene was enough to eliminate blockages, as Tdp2þ /þ
and Tdp2þ / cells were indistinguishable in ATM-deﬁcient
background (Supplementary Fig. 3). Importantly, the effect of
ATM was speciﬁc to TOP2-mediated breaks, not being observed
with ionizing radiation (Supplementary Fig. 2b), in which case,
repair ofB10% of the breaks was ATM dependent, as previously
described7, but was not affected by TDP2 deﬁciency. It is worth
noting that, as mentioned above, signalling in response to
etoposide strongly relies on ATM (Supplementary Fig. 1a), but it
only has an impact on repair efﬁciency in the absence of TDP2.
Consistent with this independence between signalling and repair,
ATM and downstream checkpoint proteins were equally activated
in Tdp2þ /þ and Tdp2 / cells (Supplementary Fig. 4).
To conﬁrm the synergism between Tdp2 and Atm in the repair
of etoposide-induced damage during G0/G1, we repeated the
analysis but using ATM chemical inhibition instead of deletion
(Fig. 2b and Supplementary Fig. 2c). As expected, incubation with
an ATM inhibitor affected repair of TOP2-induced DSBs in a
Tdp2 / but not in a Tdp2þ /þ background. This suggests that
the role of ATM in the repair of blocked DSBs depends on its
kinase activity and rules out artefacts caused by heterogeneity in
MEFs. A similar DSB-repair defect was observed when con-
ﬂuency-arrested primary ﬁbroblasts derived from A-T patients
were depleted for TDP2 and not in neither wild type nor non-
depleted controls (Fig. 2c and Supplementary Fig. 2d). In this
case, however, the effect was milder, perhaps due to an
incomplete knockdown of TDP2, as determined by residual 50
tyrosyl DNA phosphodiesterase activity (Supplementary Fig. 2e).
Finally, the effect was not restricted to quiescent cells and was
also observed in cycling conditions, both in G1 and G2 stages
(Supplementary Fig. 5). Overall, these results constitute strong
evidence of an involvement of ATM in DSB repair and suggest
that it is speciﬁcally linked to DSBs with blocked ends.
ATM function on blocked DSBs is heterochromatin independent.
In the currently accepted model, ATM is speciﬁcally required to
repair DSBs occurring at heterochromatic regions where it pro-
motes decompaction and facilitates access of the repair machin-
ery24. Since TOP2-mediated breakage requires on-going
transcription25, it should therefore rarely occur within
heterochromatin. Thus, we reasoned that the function of ATM
in opening chromatin would unlikely account for its involvement
in the repair of TOP2-blocked DSBs. In any case, to rule out
this possibility, we decided to analyse the location of etoposide-
induced gH2AX foci with respect to heterochromatin in
Tdp2 / Atm / conﬂuency-arrested primary MEFs, by
three-dimensional confocal microscopy (Fig. 3). As expected,
none of the gH2AX foci induced with etoposide colocalized with
highly dense chromocenters and only 15.45% (34 out of 220 foci
scored) were located at less than 0.4 mm (Fig. 3a), which we
considered to be heterochromatin associated. In these same
conditions, a signiﬁcantly higher percentage of the breaks
(B40%) required ATM activity for their repair (Fig. 2a),
indicating that the chromatin status of a TOP2-blocked DSB is
not a major determinant of ATM requirement for repair.
Furthermore, the overall distribution of heterochromatin-
associated foci was not signiﬁcantly changed following 24 h of
repair (Fig. 3b), with 81.92% of unrepaired foci (154 out of 188)
being located within euchromatin (Fig. 3a). We conclude that the
involvement of ATM in the repair of TOP2-blocked DSBs is
largely independent of the reported role of this protein in
facilitating repair at heterochromatin regions.
ATM function on blocked DSBs has consequences for the cell.
The incapacity to properly repair a small number or even a single
DSB can lead to cell death and/or genome rearrangements. It is
therefore conceivable that the DSB-repair defect caused by ATM
loss, although affecting a minor fraction of the lesions, underlies
the profound radiosensitivity and chromosomal instability
observed in A-T patients and cells. We exploited Tdp2 /
Atm / cells to directly address the cellular implications of
ATM-linked DSB-repair deﬁciencies, ﬁrst by monitoring cell
survival in response to etoposide treatment (Fig. 4a). Atm dele-
tion in transformed MEFs had a negligible effect on etoposide
sensitivity in a wild-type (Tdp2þ /þ ) background. In contrast,
sensitivity of Tdp2 / cells, which was mild at this low etopo-
side doses, was signiﬁcantly increased by ATM loss, correlating
with the observed DSB-repair defect (Fig. 2a). An even larger
effect was observed if ATM inhibition was used instead of dele-
tion (Fig. 4b), conﬁrming the requirement of ATM kinase activity
and ruling out differences being caused by heterogeneity intrinsic
to the MEFs or the cellular transformation process. Furthermore,
the difference observed between deletion and chemical inhibition
suggests a possible negative effect of inactive ATM and is con-
sistent with recently observed enhanced phenotypes of catalyti-
cally dead ATM26,27.
Furthermore, we addressed the impact of ATM loss on
genome integrity following etoposide treatment in Tdp2þ /þ
and Tdp2 / transformed MEFs. First, we monitored micro-
nuclei formation, which arise from the mis-segregation of
chromosomes or acentric chromosomal fragments, and is a
well-established indicator of genome instability. To restrict our
analysis to micronuclei arising during the cell cycle in which
treatment was applied, cytokinesis was blocked with cytochalasin
B and only binucleated cells were scored (Fig. 5a). Independent
deletion of either Atm or Tdp2 caused an increase in etoposide-
induced micronuclei. Interestingly, however, the levels were
further increased when both genes were simultaneously deleted,
doubling the frequency observed in either single mutant. It is
worth noting that the frequency observed corresponds to
extremely high levels of instability, with many of the cells
displaying multiple micronuclei, a qualitative difference com-
pared with single mutants. To conﬁrm these results, we scored
chromosomal aberrations in metaphase spreads (Fig. 5b). Follow-
ing etoposide treatment, Tdp2 / Atm / cells displayed a
marked increase in the number of chromosomal aberrations
observed. On average, these cells showed a striking 15% aberrant
chromosomes, which represent a 7.5-fold and 3-fold increase
when compared with single Tdp2 / and Atm / mutants,
respectively. A wide variety of aberration types was observed,
including breaks, radial chromosomes and fusions. Overall, these
results demonstrate that ATM-mediated repair promotes cell
survival and the maintenance of genome integrity in response to
blocked DSBs, presenting this particular structure as a possible
molecular trigger of important A-T symptoms. One must bear in
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mind, however, that the cell death and genome instability
phenotypes may not be uniquely caused by the blocked
DSB-repair defect, but by its combination with a defective
checkpoint that allows cell cycle progression in the presence of
DNA lesions.
ATM function on blocked DSBs prevents loss of DNA
sequence. TOP2-blocked DSBs are only one type of many pos-
sible blockages occurring in vivo. We therefore aimed at con-
ﬁrming the involvement of ATM in the repair of blocked DSBs
using a different, TOP2-independent, system in which the
structure of DNA ends could be molecularly controlled. We
started by searching for a 50 modiﬁcation that could block DNA
ends in vitro. We found that a commercially available 50-biotin
modiﬁcation was not removed from duplex oligonucleotides
in vitro by HEK293T cellular extracts, while clear a 50 tyrosyl
DNA phosphodiesterase activity was observed under the same
conditions (Supplementary Fig. 6a,b). We decided to use this
modiﬁcation to block the ends of the pEGFP-Pem1 system, which
uses reconstitution of GFP expression to measure recirculariza-
tion of a linear plasmid following transfection into mammalian
cells28 (Fig. 4a). Using PCR-mediated ampliﬁcation with primers
with different 50 end structure, we were able to generate DNA
substrates that harboured either clean 50-phosphates or blocked
50-biotins at their ends, something that was conﬁrmed by
streptavidin-mediated pull-down (Supplementary Fig. 3c). As
can be seen in Fig. 6b, repair of pEGFP-Pem1 plasmids
containing clean 50-phosphate ends was not signiﬁcantly
affected by incubation of HEK293T cells with an ATM
inhibitor, as measured by either the percentage of GFP-
expressing cells or the total accumulated GFP ﬂuorescence. In
contrast, repair of 50-biotin containing plasmids was signiﬁcantly
decreased by ATM inhibition, regardless of the quantiﬁcation
method used. As an additional control, we found that ATM was
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Figure 3 | Unrepaired TOP2-blocked DSBs are not associated with heterochromatin. Conﬂuency-arrested Atm / Tdp2 / primary MEFs were treated
as described in Fig. 1. (a) Percentage of gH2AX foci that are located within heterochromatin (Het) or euchromatin (Eu) following 0 and 24h repair after
etoposide treatment. A cutoff distance of 0.4mM from the centroid of each focus to the nearest euchromatin/heterochromatin boundary was applied.
Statistical signiﬁcance by Chi Square test is indicated. (b) Distribution of distances between gH2AX foci and heterochromatin as determined above. Bins of
0.4mm centred on the indicated distance were used for representation. (c) Example of the automatic calculation of distances between gH2AX foci (green) and
densely DAPI-stained chromocenters (blue) used for the data shown above. Both a z-stack projection (left) and a 3D reconstitution (right) are shown.
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Figure 4 | ATM promotes survival upon induction of blocked DSBs.
(a) Clonogenic survival of the indicated transformed MEFs following acute
treatment with the indicated concentrations of etoposide. Average±s.e.m.
of at least three independent experiments and statistical signiﬁcance at the
highest indicated dose by one-way ANOVA with Bonferroni post-test are
shown (*Pp0.05; **Pp0.01; ***Pp0.001). (b) As above, with or without
incubation with 10mM ATM inhibitor (KU55933).
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not required to repair a modiﬁcation such as 50 hydroxyl that
should not result in end blockage due to the existence of cellular
machinery to solve the problem (PNKP) (Supplementary Fig. 6d).
Therefore, by using a molecularly deﬁned system, we conﬁrm that
ATM speciﬁcally facilitates repair of DSBs that are blocked.
The system also allows partial loss of sequence at the repair
junction thanks to the Pem1 intron (see Fig. 6a). Thus, not only
the quantity, but also the quality of repair can be monitored,
something that can provide insights into the mechanisms
involved. For this purpose, a minimum of 46 individual events
for each condition were cloned in bacteria and subjected to
restriction analysis to determine the accuracy of the repair
process (Supplementary Fig. 7). Interestingly, ATM inhibitors
caused a qualitative change in repair of the 50-biotin but not the
50-phosphate substrates, with a marked decrease (from 20% to
5%) in the percentage of repair events not harbouring detectable
loss of sequence (Fig. 6c). However, in the clones showing DNA
loss, the average size of this deleted sequence was unchanged by
ATM inhibition (Fig. 6d). This demonstrates that ATM prevents
excessive sequence loss from DNA ends, which is indicative of its
involvement in blocked DSB end processing.
Discussion
Our study demonstrates that ATM is speciﬁcally required for the
repair of blocked DSBs. With these results in mind, it is tempting
to speculate that the observed existence of two subpopulations of
DSBs, according to their ATM dependency or independency for
repair8, to some extent might be based on the structural
heterogeneity in the ends induced by DNA-damaging agents.
Thus, ATM would not impact in the repair of DSBs with
30-hydroxyl 50-phosphate ligatable ends, or those that can be
converted into these structures by direct unblocking, while it
would greatly facilitate rejoining of DSBs with ends that are
blocked and require processing.
In addition, we observe that the role of ATM in blocked DSB
repair is independent of the chromatin status of the broken DNA,
in apparent contradiction with previous observations of a speciﬁc
role of ATM in the repair of DSBs occurring in hetero-
chromatin24. We understand, however, that blocked end and
heterochromatin models for ATM involvement in DSB repair are
not conﬂicting, and it is therefore possible to unify both
observations if one thinks that ATM is speciﬁcally required in
conditions in which repair is suboptimal, regardless of the
particular molecular reason. Alternatively, it is also possible that
heterochromatin, due to its densely packed structure, is more
prone to suffer blocked damage, such as clustered DNA lesions
and/or DNA-protein crosslinks, than more open regions. It is
worth noting that progressive cerebellar ataxia, which is perhaps
the most enigmatic (and also debilitating) symptom of A-T, could
hardly be explained based on a heterochromatin hypothesis, since
the clearest target population in the cerebellum, Purkinje cells,
possess a mostly euchromatic nucleus29. Our ﬁndings change this
picture, as blocked DSBs could also occur in Purkinje cells, and
could therefore potentially contribute to this aspect of pathology.
We would like to clarify that TOP2-mediated DSBs, although
successfully used as a tool in this study, may constitute only
one particular type of many possible physiological blockages
requiring ATM in vivo, and which could, altogether, contribute
to A-T pathogenesis. In this sense, ATM has already been
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directly implicated in two examples of blocked DSB repair
with consequences for A-T symptomatology. First, during
V(D)J recombination induced by the RAG endonucleases,
ATM promotes the stability of coding ends, which are hairpin-
blocked, but not of signal ends, which are clean30. This deﬁcit
likely contributes to immunodeﬁciency and the development
of lymphoid malignancies in A-T31. Second, meiotic
recombination, which involves the repair of DSBs covalently
blocked by the SPO11 protein, is severely compromised in the
absence of ATM and is likely the cause of sterility in A-T10,11.
Our results put forward end blockage as a possible molecular
explanation for the particular sensitivity of these systems to ATM
loss. Finally, it is worth noting that the extreme etoposide
sensitivity of double Tdp2 / Atm / cells opens the door for
the use of TDP2 inhibitors, which are currently under
development, in sporadic ATM-deﬁcient cancers32–34.
We envision mainly two complementary manners in which
ATM can regulate processing of blocked DSBs (Fig. 7). First, it
can promote nucleolytic activity to eliminate the blockage
through the action of nucleases such as the MRN complex, CtIP
and/or Artemis8,35,36, some of which have already been reported
to affect cellular response to etoposide37,38. Second, it can restrict
excessive nucleolytic degradation of DNA ends39. This can
actually operate by a direct inhibitory action on these same
nucleases40 or others such as EXO141, and/or by promoting
modiﬁcations at the DSB, such as for example gH2AX, which can
protect from nucleolytic action42. This dual impact of ATM on
DSB ends, exerted through its wide range of phosphorylation
targets, makes it an ideal candidate to orchestrate blocked DSB
processing, so it is restricted to the minimal resection necessary to
allow rejoining.
In summary, we demonstrate that ATM does indeed function
in DSB repair, but speciﬁcally to limit the potentially detrimental
consequences of blocked DNA ends. If not properly dealt with,
these lesions can impact cell survival and genome integrity, which
can contribute to the development of A-T symptomatology.
Determining the identity of physiologically occurring blockages
and their speciﬁc inﬂuence on pathogenesis should therefore
attract future efforts to unravel the aetiology of this devastating
disease.
Methods
Cells and cell culture. Primary MEFs were isolated from crosses between
Tdp2 / and Atm / mice19,43 at day 13 p.c. and cultured at 37 C, 5% CO2,
3% O2 in Dubelcco’s Modiﬁed Eagle’s Medium (DMEM) supplemented with
penicillin, streptomycin, 15% FCS and non-essential amino acids. All experiments
were carried out between P1 and P5. MEFs were transformed by retroviral delivery
of T121, a fragment of the SV40 large T antigen that antagonizes the three Rb
family members but not p53 (ref. 19). Transformed MEFs and HEK293T cells
were maintained at 37 C, 5% CO2 in DMEM supplemented with penicillin,
streptomycin and 10% FCS. A-T (Coriell’s Repository GM05823D) and BJ1
primary ﬁbroblasts were cultured at 37 C, 5% CO2, in DMEM supplemented
with penicillin, streptomycin and 15% FCS.
Selective labelling of protein-blocked DNA ends. The selective labelling of
protein-blocked DNA ends (SLOPE) assay is a modiﬁcation of selective labelling of
TOP2 cleavage sites (SLOT) protocol20. Cells were treated 30min with 100 mM
etoposide or vehicle (DMSO), and 300 after drug removal (to allow reversal of
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cleavage complexes) genomic DNA was extracted with the Qiagen Blood and
Tissue Kit, which includes proteinase K treatment. Tyrosine residues that remain
covalently linked to DNA were labelled with biotin using EDC and amine-PEG3-
biotin (Thermo Scientiﬁc). DNA was precipitated to eliminate unreacted amine-
PEG3-biotin and resuspended in TE buffer. Five hundred nanograms of DNA were
dotted on a Hybond-Hþ (Amersham Bioscience) membrane and cross-linked with
70,000 mJ cm 2 UV. The membrane was blocked with Odyssey blocking buffer
(LI-COR Biosciences) with 1% SDS, incubated with IRDye Streptavidin 800CW, 1/
10,000 (LI-COR Biosciences) in the same buffer, washed (three times in TBS-0.1%
Tween20) and allowed to dry. Dots were analysed and quantiﬁed in Odyssey CLx
with ImageStudio Odyssey CLx Software. The results are related to an internal
control of the same labelling protocol performed on plasmid DNA.
Immunoﬂuorescence. Cells were grown on coverslips for 7 days until conﬂuency-
arrested, treated as indicated and ﬁxed 10min in ice-cold methanol or 4% PFA-
PBS. Cells were then permeabilized (2min in PBS-0.2% Triton X-100), blocked
(30min in PBS-5% BSA) and incubated with the required primary antibodies
(1–3 h in PBS-1% BSA). Cells were then washed (three times in PBS-0.1% Tween
20), incubated for 30min with the corresponding AlexaFluor-conjugated secondary
antibodies (1/1,000 dilution in 1% BSA-PBS) and washed again as described above.
Finally, they were counterstained with DAPI (Sigma) and mounted in Vectashield
(Vector Labs). gH2AX foci were manually counted (double-blind) in 40 cells from
each experimental condition. Primary antibodies were used at the indicated dilu-
tion: gH2AX (Millipore, 05-636), 1/1,000; a-Tubulin (Abcam, ab18251), 1/2,000;
Vinculin hVIN-1 (Sigma, V9131) 1/2,000.
TOPIIb cleavage complexes. Conﬂuency arrested primary MEFs were treated 1 h
with 100 mM etoposide or vehicle (DMSO), immediately lysed in 1% Sarkosyl
(Sigma) and processed according to the in vivo complex of enzyme (ICE) assay44.
Samples were centrifuged at 57,000 r.p.m. for 20 h at 25 C using 3.3ml
13 33mm polyallomer Optiseal tubes (Beckman Coulter) in a TLN100 rotor
(Beckman Coulter). 2.5 mg of precipitated DNA was transferred onto Hybond ECL
membranes (GE Healthcare) using a Bio-Dot SF Microﬁltration Apparatus
(Biorad). Membranes were blocked 1 h with Odyssey Blocking Buffer (LI-COR
Biosciences), incubated with 1/1,000 anti-TOP2b antibody (Santa Cruz, sc-13059),
in Odyssey Blocking Buffer-0.1% Tween20, washed (three times with TBS-0.1%
Tween20), incubated with 1/15,000 IRDye 800CW Goat anti-Rabbit IgG (LI-COR)
and ﬁnally washed (three times with TBS-0.1%-Tween20 and three times with
TBS). Once the membranes were dry, slots were analysed and quantiﬁed in
Odyssey CLx using ImageStudio Odyssey CLx Software.
TDP2 knockdown. Lentiviral vectors for TDP2 knockdown (pLKO.1-puro-Tdp2-
2; SIGMA, clone TRCN0000003072) and empty control (pLKO.1-puro) were
generated in HEK293T transfected with the packaging vectors pCMVDR8.91 and
pMDG. A-T and BJ1 primary ﬁbroblasts were infected with pLKO.1-puro-Tdp2-2
or pLKO.1-puro lentiviruses in 100mm dishes, incubated for 3 days and then
placed under puromycin selection (1 mgml 1) for 7 days.
50 activity in vitro. For the preparation of labelled double-stranded 50-phospho-
tyrosyl, 50-phosphobiotin and 50-phosphate substrates, 50- TAT ACT TCT CTT
TCC AGG GCT ATG T-30 oligonucleotides with tyrosine (Midland Certiﬁed
Reagents), biotin (Sigma) or phosphate (Sigma) modiﬁcations at the 50 end were
annealed to 50-AGA CAT AGC CCT GGA AAG AGA AGT ATA-30 (Sigma) and
labelled in the presence of [a-32P]-dCTP, ddTTP and Klenow polymerase. Cell
extracts were prepared by mild sonication in Lysis Buffer (40mM Tris–HCl, pH
7.5, 100mM NaCl, 0.1% Tween-20, 1mM DTT) supplemented with 1mM PMSF
and protease inhibitor cocktail (Sigma) followed by clariﬁcation 10min 16,500 g
4 C. Protein concentration was measured with Bradford reagent (Sigma).
50 reactions contained 50 nM substrate, 80 mM competitor single-stranded oligo-
nucleotide and the indicated amount of cellular extract in a total volume of 6 ml
Reaction Buffer (50mM Tris–Cl, pH 7.5, 50mM KCl, 1mM MgCl2, 1mM DTT,
100 mgml 1 BSA). Reactions were stopped by the addition of 3 ml 3 Formamide
Loading Buffer and 5min 95 C incubation. Samples were resolved by denaturing
polyacrylamide gel electrophoresis and analysed by phosphorimaging in a Fujiﬁlm
FLA5100 device (GE Healthcare).
cH2AX foci in speciﬁc cell cycle stages. Immunoﬂuorescence was performed as
described above with the following modiﬁcations. Fixation was performed 10min at
room temperature in 4% PFA-PBS. Cyclin A staining was used to distinguish G1 and
S/G2 cells. To exclude replicating cells, 5-ethynyl-20-deoxyuridine (EdU, Invitrogen)
was added throughout treatment and repair at a ﬁnal concentration of 10mM. Click
chemistry reaction was performed by incubating (30min r.t.) with 1mM AlexaFluor
647-conjugated azide (Invitrogen) in reaction cocktail (100mM TrisHCl pH 8.5,
1mM CuSO4, 100mM ascorbic acid). gH2AX foci were manually counted (double-
blind) in 40 G1 cells (Cyclin A negative) or 20 G2 cells (Cyclin A positive EdU
negative) from each experimental condition. Antibodies were used at the indicated
dilution: gH2AX (Millipore, 05-636), 1/1,000; Cyclin A (Santa Cruz, sc-751), 1/200.
Western blot. Conﬂuency-arrested primary MEFs were resuspended on ice using
a cell scraper 30min after treatment with the indicated concentration of etoposide.
They were lysed in Laemli buffer and boiled at 96 C for 5min. Protein con-
centration was measured by Pierce 660 nm Protein Assay with Ionic detergent
compatibility reagent (Thermo Scientiﬁc). Thirty micrograms of sample was run in
NuPAGE Tris-Acetate Mini gels 3–8% (Novex) and transferred to Immobilon-FL
Transfer Membranes (Millipore). Membranes were blocked in Odyssey Blocking
Buffer (LI-COR Biosciences) incubated with primary antibodies in Odyssey
Blocking Buffer-0.1% Tween20 and washed (three times in TBS-0.1% Tween20).
They were then incubated with the corresponding IRDye-conjugated secondary
antibodies in Odyssey Blocking Buffer-0.02% to 0.1% Tween20 and washed (three
times in TBS-0.1% Tween20 and 1 in TBS buffer). Membranes were analyzed in
Odyssey CLx with ImageStudio Odyssey CLx Software. Primary antibodies were
used at the indicated dilution: ATM (Sigma, MAT3-4G10/8), 1/1,000; ATM pS1981
(Cell Signaling, #4526), 1/1,000; p-CHK2 Thr68 (Cell Signaling, #2661), 1/1,000;
p-p53 Ser15 (Cell Signaling, #9284), 1/1,000; p-CHK1 Ser345 (Cell Signaling,
#2341), 1/1,000; a-tubulin (Sigma, T9026), 1/50,000.
Image processing. An in-house MATLAB R2012a-based application was designed
to segment nuclei images. For each nucleus, a series of Z-sections (0.21mm step) were
obtained using a Leica TCS-SP5 confocal microscope with a HCX PL APO 63x/
1.40lBL objective. These series were segmented to obtain the number, position,
intensity and volume values of gH2AX foci and heterochromatin (G and B compo-
nents of the RGB image, respectively). The segmentation from the different sections
was integrated to reconstitute the 3D information of each entire nucleus. Using this
reconstitution, the distance between each focus and the nearest euchromatin/het-
erochromatin boundary in the 3D space was determined.
Clonogenic survival assays. Survival assays were carried out seeding 2,000 cells in
100mm dishes, in duplicate for each experimental condition. After 12 h, cells were
preincubated with 10 mM ATM inhibitor KU55933 (Tocris) or vehicle for 1 h.
The indicated concentration of etoposide was added and cells were incubated for
additional 3 h. Following one wash with PBS, fresh medium was added and cells
were incubated for 10–14 days. Dishes were ﬁxed and stained for colony scoring in
Crystal Violet solution (0.5% Crystal violet in 20% ethanol). The surviving fraction
at each dose was calculated by dividing the average number of visible colonies in
treated versus untreated dishes.
A-T symptomatology
DSBs
Cell death 
Genome
instability 
Degradation
Repair
Processing
ATM
Figure 7 | Model for ATM involvement in blocked DSB repair. ATM promotes processing of blocked DSBs and inhibits excessive degradation.
This promotes efﬁcient and accurate repair, preventing the accumulation of unrepaired DSBs, cell death and genome instability, which can trigger the
development of A-T symptomatology.
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Cytogenetic analysis. Micronuclei were analysed in transformed MEFs previously
seeded onto coverslips. Following treatment, cytochalasin B (Sigma) was added at
4mgml 1. Twenty-two hours post treatment, cells were ﬁxed and subjected to DAPI
staining as described above. Only binucleated cells were scored, which was conﬁrmed
by visualization of the cytoplasm with Tubulin and Vinculin immunoﬂuorescence
(performed as described above). Chromosomal aberrations were scored in Giemsa-
stained metaphase spreads. Following treatment, recovery in fresh medium was
allowed for 2 h, and demecolcine (Sigma) was added at a ﬁnal concentration of
0.2mgml 1. Four hours later, cells were collected by trypsinization, subjected to
hypotonic shock for 1 h at 37 C in 0.3M sodium citrate, and ﬁxed in 3:1 metha-
nol:acetic acid solution. Cells were dropped onto acetic acid-humidiﬁed slides and
stained 20min in Giemsa-modiﬁed (Sigma) solution (5% v/v in H2O).
Validation of pEGF-Pem1 substrates. The structure of 50 DNA ends was analysed
by streptavidin-mediated precipitation. Dynabeads (10 mg) M-270 Streptavidin
magnetic beads (Invitrogen) were prewashed (3 in 5mM Tris–HCl pH 7.5,
0.5mM EDTA in the presence of 1M NaCl) and incubated with 100 ng of puriﬁed
PCR products in the same buffer for 1 h. Beads were then washed 4 in the same
buffer, gradually decreasing NaCl concentration to 0. Finally, DNA was eluted
by 2 h incubation with BglII restriction enzyme (New England Biolabs) in the
recommended buffer. Input, unbound and bound DNA was analysed by agarose
gel electrophoresis.
Plasmid-circularization assays. Substrates were generated by PCR-mediated
ampliﬁcation of plasmid pEGFP-Pem1-Ad228 with primers 50-AAT TCT TCT
CTT TCC AGG GCT AT GT-30 and 50- AAT TCA TCC CCA GAA ATG TAA
CTT G-30 harbouring phosphate or biotin moieties at 50 ends (Sigma). DNA of the
correct size was then gel-puriﬁed and transfected into HEK293T cells, pretreated
for 30min with 10mM ATM inhibitor KU55933 (Tocris) or vehicle. Sixteen hours
later, cells were analysed by FACS. Individual repair events were cloned in E. coli by
plasmid rescue from transfected cells and analysed by digestion with DraI.
Statistical analysis. In all cases the indicated statistical test was applied using
Prism 5 package (Graphpad).
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